ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

R01 Payline To Increase From 21st to 22nd Percentile; Barcelona Hospital Wins BMS Cancer Research Grant

June 14, 2002

In Brief: Sartorelli AACI President, McInTyre President Elect; Moertel to Receive ACCC Clinical Award

July 10, 1987

Maryland to Use $1B In Tobacco Funds For Cancer Research, Anti-Smoking Program

June 4, 1999

Abstracts of Papers From ASCO Meeting

April 14, 1978